Vincent Aurentz - Director at Inhibikase Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
IKT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Vincent Aurentz since 10/6/2024

Holdings reported by Vincent Aurentz for Inhibikase Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 766K $1.29M $1.68 Feb 21, 2025 Direct
Stock Option (Right to Buy) 108K Jun 30, 2025 Direct Common Stock

Transactions reported by Vincent Aurentz for Inhibikase Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.